Compugen (CGEN) Other Non-Current Assets (2009 - 2026)

Compugen's (CGEN) quarterly Other Non-Current Assets came in at $1.3 million in Q1 2026, down 20.84% year-on-year from $1.6 million in Q1 2025, and little changed quarter-over-quarter from $1.3 million in Q4 2025.

Compugen (CGEN) Other Non-Current Assets (2009 - 2026) Analysis & Trends

Compugen has disclosed Other Non-Current Assets across 18 years of filings, most recently posting $1.3 million for Q1 2026.

  • Other Non-Current Assets for Q1 2026 came in at $1.3 million, down 20.84% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 million (down 20.84% YoY), and the FY2025 annual result was $1.3 million, down 31.51% from the prior year.
  • Other Non-Current Assets came in at $1.3 million for Q1 2026 at Compugen, roughly flat from $1.3 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $1.9 million in Q1 2022 to a low of $362000.0 in Q4 2022.
  • The 5-year median for Other Non-Current Assets is $1.5 million (2025), against an average of $1.3 million.
  • Peak annual rise in Other Non-Current Assets reached 417.26% in 2024, while the deepest fall reached 51.05% in 2024.
  • Compugen's Other Non-Current Assets stood at $362000.0 in 2022, then rose by 0.83% to $365000.0 in 2023, then jumped by 417.26% to $1.9 million in 2024, then slumped by 31.51% to $1.3 million in 2025, then rose by 0.15% to $1.3 million in 2026.
  • The last three Other Non-Current Assets figures came in at $1.3 million (Q1 2026), $1.3 million (Q4 2025), and $1.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 12.40 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 60,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.26 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Compugen 189.59 Mn 97.83 Mn 352,000.00 1.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.30 Mn
Dec 31, 2025 1.29 Mn
Sep 30, 2025 1.73 Mn
Jun 30, 2025 1.74 Mn
Mar 31, 2025 1.64 Mn
Dec 31, 2024 1.89 Mn
Sep 30, 2024 1.10 Mn
Mar 31, 2024 934,000.00
Dec 31, 2023 365,000.00
Sep 30, 2023 1.91 Mn
Jun 30, 2023 615,000.00
Mar 31, 2023 1.91 Mn
Dec 31, 2022 362,000.00
Sep 30, 2022 1.91 Mn
Jun 30, 2022 363,000.00
Mar 31, 2022 1.92 Mn
Dec 31, 2021 713,000.00
Sep 30, 2021 1.91 Mn
Jun 30, 2021 681,000.00
Mar 31, 2021 1.88 Mn